We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Taro Pharmaceutical Industries Ltd | NYSE:TARO | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.08 | -0.19% | 42.40 | 42.49 | 42.23 | 42.34 | 27,112 | 01:00:00 |
Earnings Call to be Conducted Tuesday, November 6 at 8:00 am EST
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2018, on Monday, November 5, 2018.
The Company will conduct an earnings call at 8:00 am EST on Tuesday, November 6, 2018, where senior management will discuss the Company’s performance and answer questions from participants.
The earnings release will be accessible on Taro’s website at www.taro.com.
Earnings Call (8:00 am EST on Tuesday, November 6, 2018)
To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.
Summary of events
Event Date and time Telephone number/ website Earnings release November 5, 2018 (AMC)www.taro.com
Earnings conference call 8:00 am ESTNovember 6, 2018
Participant Toll-Free Dial-In Number: +1 (844) 421-0601
Participant International Dial-In Number: +1 (716) 247-5800
Conference ID: 2871389
Via audio webcast, details of which will be made available on www.taro.com
Replay of conference call November 6, 2018 toNovember 18, 2018
+ 1 (855) 859-2056 or +1 (404) 537-3406
Conference ID: 2871389
Via audio webcast playback, details of which will be made available on www.taro.com
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181029005695/en/
Taro Pharmaceutical Industries Ltd.Mariano A. BalaguerVP, CFO(914) 345-9001Mariano.Balaguer@taro.comorWilliam J. CooteAVP, Business Finance, Treasurer and Investor Relations(914) 345-9001William.Coote@taro.com
1 Year Taro Pharmaceutical Indu... Chart |
1 Month Taro Pharmaceutical Indu... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions